RUNX3 and head and neck cancer: In the same study, cells presenting with low levels of miR-145, after being transfected with miR-145 mimics, showed a better result after the treatment via the increase in apoptotic processes and inhibition of progression through the pathway of runt-related transcription factor 3 (RUNX3), an oncogene involved in head and neck cancers [17].